Tab2 participates in the activation of the immune deficiency (Imd) signalling pathway through its interaction with the product of transforming growth factor (TGF) beta-activated kinase 1 (Tak1) [75]. The gene discussed is TAB2; the disease is hyperinsulinemic hypoglycemia, familial, 4.